Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangrelor for Reperfusion Injury in STEMI
NCT03102723Phase 2Unknown
- Sponsor
- National Heart Centre Singapore
- Start
- Oct 2017
- Primary completion
- Dec 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of cangrelor in ST-segment elevation myocardial infarction (STEMI), sponsored by National Heart Centre Singapore. Status: unknown.
02
Drugs
cangrelor
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03102723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03102723.